However, almost studies exploring the neprilysin in patients with CKD enrolled the patients who were not receiving dialysis, and no evidence exists on circulating neprilysin as a pathologic surrogate to predict the incident CV events in patients undergoing HD treatment. The gene discussed is MME; the disease is chronic kidney disease.